Quarterly ResultAug 6, 2026, 05:03 PM
Dentsply Sirona Q2 Net Income $37M, EPS $0.18
AI Summary
Dentsply Sirona reported a net income of $37 million, or $0.18 diluted EPS, for the second quarter of 2026, a significant improvement from a net loss of $45 million, or $(0.22) diluted EPS, in the prior year. Net sales for the quarter decreased to $898 million from $936 million. The company incurred $57 million in restructuring charges under the 2026 Plan and repurchased $12 million of common stock.
Key Highlights
- Q2 2026 Net Income attributable to Dentsply Sirona was $37 million, compared to a $(45) million loss in Q2 2025.
- Q2 2026 Diluted EPS was $0.18, a turnaround from $(0.22) in Q2 2025.
- Q2 2026 Net Sales decreased to $898 million from $936 million in Q2 2025.
- The company incurred $57 million in restructuring charges by June 30, 2026, under the 2026 Plan.
- $12 million was spent to repurchase 1.3 million shares in Q2 2026, with $1.2 billion remaining authorization.
- Net cash provided by operating activities for six months ended June 30, 2026, was $139 million, up from $55 million in 2025.
- Wellspect Healthcare Q2 2026 net sales increased to $86 million from $80 million in Q2 2025.
- Orthodontic and Implant Solutions Q2 2026 net sales decreased to $197 million from $226 million in Q2 2025.
Price Impact
More from XRAY